Last 48 quarters of trend data · Healthcare · Biotechnology
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 167.00 | — | — | — | 52.44 | 445.24 | 30.67 | 63.04 | 38.73 | — | 34.63 | 211.63 | 161.33 | — | — | — | — | — | — | — | — |
| — | — | — | — | +35.4% | — | -11.4% | -70.2% | -76.0% | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 3.06 | 3.01 | 2.09 | 3.98 | 5.09 | 3.81 | 5.15 | 6.09 | 6.39 | 4.92 | 5.55 | 5.04 | 5.41 | 5.56 | 6.66 | 9.62 | 6.10 | 12.79 | 19.32 | 21.92 | 12.24 |
| — | -20.9% | -59.3% | -34.6% | -20.3% | -22.7% | -7.2% | +20.7% | +18.0% | -11.5% | -16.7% | -47.6% | -11.3% | -56.5% | -65.5% | -56.1% | -50.1% | -12.4% | +39.4% | +120.2% | +74.0% | |
| P/B Ratio | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/FCF | 77.93 | — | — | — | 18.71 | 37.18 | — | 23.66 | 56.57 | 413.87 | 85.63 | 18.65 | — | — | — | — | — | — | — | — | — |
| — | — | — | — | -66.9% | -91.0% | — | +26.9% | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | 28.68 | 65.93 | 83.83 | — | 20.58 | 36.46 | 16.18 | 16.96 | 32.02 | 20.90 | 20.99 | 32.24 | 50.54 | 97.76 | — | — | — | — | — | — | — |
| — | +80.8% | +418.2% | — | -35.7% | +74.5% | -22.9% | -47.4% | -36.7% | -78.6% | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | 37.76 | 60.94 | — | — | 29.31 | 40.48 | 16.64 | 31.08 | 23.18 | 34.86 | 19.17 | 36.46 | 46.62 | 78.51 | — | — | — | — | — | — | — |
| — | +50.5% | — | — | +26.4% | +16.1% | -13.2% | -14.8% | -50.3% | -55.6% | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 82.5% | 73.0% | 75.8% | 78.5% | 75.4% | 73.1% | 77.6% | 74.5% | 74.3% | 71.8% | 71.9% | 69.1% | 72.2% | 70.7% | 60.1% | 55.3% | 46.8% | 31.6% | 8.3% | 8.6% | 55.5% |
| — | -0.2% | -2.4% | +5.4% | +1.5% | +1.8% | +7.9% | +7.8% | +2.9% | +1.6% | +19.7% | +25.0% | +54.2% | +123.5% | +625.0% | +540.0% | -15.6% | -44.8% | -85.3% | -86.9% | -16.3% | |
| Operating Margin | 11.1% | -0.3% | -3.3% | -6.9% | 22.9% | 6.9% | 28.5% | 34.5% | 18.2% | 22.9% | 25.2% | 13.4% | 9.9% | 3.5% | -14.8% | -35.5% | -29.3% | -108.3% | -177.3% | -191.5% | -29.7% |
| — | -104.6% | -111.6% | -119.9% | +25.6% | -69.8% | +12.7% | +156.8% | +83.1% | +548.1% | +270.9% | +137.9% | +134.0% | +103.3% | +91.7% | +81.5% | +1.3% | -145.3% | -399.2% | -48.7% | +50.1% | |
| Net Margin | 1.7% | -17.4% | -18.4% | -14.2% | 9.7% | 0.9% | 16.8% | 9.7% | 16.5% | -2.8% | 16.0% | 2.4% | 3.4% | -10.8% | -24.1% | -49.8% | -44.0% | -153.6% | -216.8% | -224.2% | -19.9% |
| — | -2093.4% | -209.8% | -247.4% | -41.0% | +131.4% | +4.7% | +303.5% | +390.8% | +74.3% | +166.5% | +104.8% | +107.6% | +92.9% | +88.9% | +77.8% | -120.6% | -0.7% | -192.7% | -56.6% | +72.8% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| ROA | 1.0% | -2.6% | -2.2% | -2.5% | 1.8% | 0.2% | 3.3% | 1.7% | 2.5% | -0.4% | 2.2% | 0.4% | 0.5% | -1.7% | -3.3% | -6.1% | -5.0% | -9.8% | -8.3% | -10.0% | -1.8% |
| — | -1685.2% | -166.1% | -243.3% | -30.7% | +137.3% | +47.2% | +391.2% | +368.4% | +74.7% | +167.4% | +105.8% | +110.9% | +82.4% | +60.0% | +39.3% | -176.2% | +21.3% | -36.9% | +61.2% | +84.1% | |
| ROIC | 21.6% | -0.1% | -0.7% | -2.9% | 26.1% | — | — | 88316.7% | — | — | — | — | — | — | — | — | — | — | — | -4585.7% | -11.7% |
| — | — | — | -100.0% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Debt / EBITDA | 9.27 | 54.70 | 128.55 | — | 10.50 | 5.91 | 1.89 | 5.39 | 15.63 | 12.38 | 14.55 | 28.98 | 43.01 | 85.66 | — | — | — | — | — | — | — |
| — | +825.0% | +6685.9% | — | -32.9% | -52.2% | -87.0% | -81.4% | -63.7% | -85.5% | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 1.70 | 1.72 | 1.87 | 1.70 | 3.29 | 2.50 | 2.36 | 3.28 | 4.54 | 4.07 | 3.84 | 3.59 | 2.34 | 2.37 | 2.73 | 3.49 | 3.66 | 3.25 | 3.44 | 4.54 | 3.18 |
| — | -31.1% | -20.9% | -48.0% | -27.6% | -38.7% | -38.4% | -8.6% | +94.2% | +71.6% | +40.6% | +2.7% | -36.1% | -26.9% | -20.8% | -23.1% | +15.2% | +9.1% | -12.7% | +321.0% | +409.0% | |
| Quick Ratio | 1.50 | 1.41 | 1.50 | 1.50 | 3.04 | 2.24 | 2.11 | 2.94 | 4.17 | 3.76 | 3.57 | 3.31 | 2.06 | 2.11 | 2.46 | 3.17 | 3.36 | 2.90 | 3.29 | 4.39 | 3.03 |
| — | -37.1% | -28.9% | -49.0% | -27.2% | -40.5% | -40.8% | -11.3% | +102.7% | +78.1% | +45.2% | +4.6% | -38.7% | -27.2% | -25.3% | -27.9% | +10.7% | +1.7% | -15.0% | +334.5% | +423.6% | |
| Interest Coverage | 1.10 | 0.55 | -0.32 | -0.59 | 2.06 | 1.15 | 2.28 | 2.13 | 2.54 | 0.87 | 2.18 | 1.55 | 1.33 | 0.44 | -0.88 | -2.39 | -1.73 | -2.19 | -4.08 | -5.77 | -0.58 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying MNKD stock.
MannKind Corporation's current P/E is 167.0x. The average P/E over the last 1 quarters is 52.4x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
MannKind Corporation's current operating margin is 11.1%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking MannKind Corporation's business trajectory between earnings reports.